Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135,765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy.
Gao F, Jing P, Liu J, Lu Y, Zhang P, Han W, Liu G, Ru N, Cui G, Sun C, Che Y, Zhang H, Hu Q, Wang HY, Wu Y, Guan C, Fu Q, Ma Z, Yu B. Gao F, et al. Among authors: liu j, liu g. J Hepatocell Carcinoma. 2015 Jun 10;2:57-68. doi: 10.2147/JHC.S80756. eCollection 2015. J Hepatocell Carcinoma. 2015. PMID: 27508195 Free PMC article.
Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy.
Yu B, Lu Y, Gao F, Jing P, Wei H, Zhang P, Liu G, Ru N, Cui G, Xu X, Sun C, Guan C, Che Y, Wu Y, Ma Z, Fu Q, Liu J, Wang HY. Yu B, et al. Among authors: liu j, liu g. Lung Cancer (Auckl). 2015 Jan 7;6:1-11. doi: 10.2147/LCTT.S70679. eCollection 2015. Lung Cancer (Auckl). 2015. PMID: 28210146 Free PMC article.
135,765 results
You have reached the last available page of results. Please see the User Guide for more information.